AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA's new drug safety board under scrutiny.(Practice Trends)

OB GYN News

| March 01, 2005 | Silverman, Jennifer | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Many questions surround the authority of a new drug safety board that would oversee the management of drug safety and provide emerging information to physicians and patients about the benefits and risks of medicines on the market.

Such a board is one of several steps that Health and Human Services Secretary Mike Leavitt is taking to improve oversight and "openness" at the Food and Drug Administration.

"Our goal is to prepare the agency for these new demands by improving the way we monitor and respond to possible adverse health consequences that may arise regarding drugs that have been approved for sale to U.S. consumers," said acting FDA Commissioner Lester Crawford, D.V.M., Ph.D.

The drug safety board is being touted as an independent entity, yet lawmakers and consumer groups have questioned how much independence or authority the board will actually have.

Larry Sasich, a pharmacist and research analyst for Public Citizen, noted that recommendations and concerns of the FDA's current Office of Drug Safety, which is a subunit of the Office of New Drugs, are often ignored by the agency's new drug reviewers.

If the new board reports in a similar manner, "it may be a stretch to call it an independent board," Mr. Sasich said.

Secretary Leavitt said that the new board would resolve disagreements over approaches to drug safety issues, oversee development and implementation of center-wide drug safety policies, and assess the need for MedGuides.

Related articles from newspapers, magazines, journals, and more
Drug safety: improvement needed in FDA's postmarket decision-making & oversight...
Newspaper article from: Biomedical Market Newsletter January 1, 2006 700+ words
...the effectiveness of FDA's postmarket drug safety decision-making process...address all gaps. FDA's newly created Drug Safety Oversight Board may...also recommends that FDA systematically track postmarket drug safety issues, revise and...
FDA plans reorganization to improve drug safety.(Rx)
Magazine article from: Internal Medicine News Schneider, Mary Ellen January 1, 2006 700+ words
...s approach to drug safety and to help improve...development. The FDA plans to appoint...the Office of Drug Safety independent from...reviewing drugs, FDA staff members...improvements in drug safety need to happen outside the FDA, said Dr. Curt...
FDA restructuring aims to address drug safety.(Practice Trends)
Magazine article from: Skin & Allergy News Schneider, Mary Ellen January 1, 2006 700+ words
...s approach to drug safety and to help improve...development. The FDA plans to appoint...the Office of Drug Safety independent from...reviewing drugs, FDA staff members...improvements in drug safety need to happen outside the FDA, said Curt D...
FDA reorganizing to improve drug safety, development.(Practice Trends)
Magazine article from: OB GYN News Schneider, Mary Ellen January 15, 2006 700+ words
...s approach to drug safety and to help improve...development. The FDA plans to appoint...the Office of Drug Safety independent from...reviewing drugs, FDA staff members...improvements in drug safety need to happen outside the FDA, said Curt D...
US FDA sets up Drug Safety Oversight Board, will inform public about emerging...
Newspaper article from: Pharma Marketletter February 21, 2005 700+ words
...and medicine at the FDA Office of Drug Safety, who told a Senate...oversee the management of drug safety issues within the FDA Center for Drug Evaluation...implementation of CDER drug safety policies. It will comprise FDA members and medical...
FDA vows transformation, better drug safety.
Magazine article from: Trial Porter, Rebecca April 1, 2007 700+ words
...program to review postmarket drug safety. The FDA came under fire last year in...Burtka, GAO Report Criticizes FDA Drug Safety Oversight, TRIAL 22 (July...made 25 recommendations to the FDA to improve drug safety, including concrete steps...
FDA names new Director of Drug Safety; Goals for Center for Drugs...
Press release article from: M2 Presswire October 20, 2005 700+ words
...PRESSWIRE-20 October 2005-US FDA: FDA names new Director of Drug Safety; Goals for Center for Drugs...adverse drug events (such as the Drug Safety Oversight Board and the Medwatch program), and represent FDA and CDER in scientific and...
IOM report: Drug safety issues point to FDA fund imbalance.
Newspaper article from: Medical Device Daily October 3, 2006 700+ words
IOM report: Drug safety issues point to FDA fund ?imbalance? By...ranging criticism of the FDA?s drug safety oversight abilities...Initiative to modernize the FDA?s mission, the creation of its Drug Safety Oversight Board, improved...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA